Advantages of fixed combinations;Intérêt des combinaisons fixes

Journal Francais d'Ophtalmologie

Volumn 31, Issue 6 PART 2, 2008, Pages

  Lachkar, Y ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

fixed combination; Glaucoma; medical treatment; monotherapy; ocular hypertension

Indexed keywords

ARTICLE; DRUG COMBINATION; DRUG THERAPY; GLAUCOMA; HUMAN;

DRUG THERAPY; DRUG THERAPY, COMBINATION; GLAUCOMA; HUMANS;

EID: 49549086436     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(08)73691-X     Document Type: Article

References (11)

1. European Glaucoma Society. Terminology and guidelines for Glaucoma, IInd edition. Editrice Dogma, Savona, Italy.
2. Lee B.L., Wilson M.R., and Ocular Hypertension Study (OHTS). Ocular Hypertension treatment Study (OHTS) commentary. Curr Opin Ophthalmol 14 (2003) 74-77
3. Kass M.A. The Ocular Hypertension Treatment Study: safety and efficacy of topical ocular hypotensive medication in preventing or delaying the onset of primary open angle glaucoma. Arch Ophthalmol 120 (2002) 701-713
4. Brubaker R.F., Schoff E.O., Nau C.B., et al. Effects of AGN 192024, a new ocular hypotensive agent. Am J Ophthalmol 131 (2001) 19-24
5. Woodward D.F., Krauss A.H., Chen J., et al. The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol 45 (2001) S337-S345
6. Bron A., Nordmann J.P., Baudouin C., et al. Glaucome et hypertonie oculaire : importance de la pression intra-oculaire cible dans la prise en charge thérapeutique en France. J Fr Ophtalmol 26 (2003) 895-903
7. Patel S.C., and Spaeth G.L. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 26 (1995) 234-236
8. Chrai S.S., Makoid M.C., Eriksen S.P., et al. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J Pharm Sci 63 (1974) 333-338
9. Serle J., Toor A., Fahim M., et al. The effect of varying dosing intervals on the efficacy ointraocular pressure lowering drugs. Invest Ophthalmol Vis Sci 45 (2004) 974 ARVO e-abstract
10. Diestelhorst M., Larsson L.I., and European Latanoprost Fixed Combination Study Group. Br J Ophthalmol 88 (2004) 199-203
11. Diestelhorst M., Larsson L.I., and Fixed Combination Study Group. European-Canadian Latanoprost. Ophthalmology 113 (2006) 70-76